首页> 外文期刊>Avian Pathology >Comparison of infectious bursal disease live vaccines and a HVT-IBD vector vaccine and their effects on the immune system of commercial layer pullets
【24h】

Comparison of infectious bursal disease live vaccines and a HVT-IBD vector vaccine and their effects on the immune system of commercial layer pullets

机译:传染性法氏囊病活疫苗和HVT-IBD载体疫苗的比较及其对商业蛋鸡的免疫系统的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Infectious bursal disease (IBD) is an economically important disease affecting poultry production worldwide. Previous experimental studies indicated that IBD live vaccination may induce transient immunosuppression, leading to suboptimal vaccine responses and therefore insufficient protection against other pathogens. Layer pullets are commonly not only vaccinated against IBD within their rearing period, but also against a variety of other pathogens. Therefore, it is of interest to investigate the effects of different IBD vaccination regimes on conventionally applied vaccines against other pathogens, and possible protection against widely spread very virulent IBD-virus (vvIBDV). A commercially available Herpesvirus of turkey vector vaccine (vHVT-IBD) expressing viral protein 2 of IBDV, and two IBD live vaccines were compared in commercial pullets for their effects on circulating B cell numbers, the ability of vaccinated birds to mount a humoral immune response against different antigens as well as their ability to induce protection against vvIBDV challenge. The results of this study demonstrate a clear immunosuppressive effect of the intermediate plus IBD live vaccine on the humoral branch of the immune system. On the other hand, no detectable effects of vHVT-IBD vaccination on these parameters were observed. All tested IBD vaccines protected against clinical IBD, although none induced sterile immunity in commercial layer pullets. vHVT-IBD-vaccinated birds showed significantly less lesions after vvIBDV challenge than IBD live-vaccinated or non-vaccinated birds (P 0.05). Therefore, vHVT-IBD may be a suitable alternative to conventional IBD live vaccines, and may be applied even in the presence of maternally derived IBD antibodies without induction of detectable humoral immunosuppression.
机译:传染性法氏囊病(IBD)是一种经济上重要的疾病,会影响全世界的家禽生产。先前的实验研究表明,IBD活疫苗接种可能会导致短暂的免疫抑制,导致次优的疫苗反应,因此对其他病原体的保护作用不足。蛋鸡通常不仅在其饲养期间针对IBD进行了疫苗接种,而且还针对多种其他病原体进行了疫苗接种。因此,研究不同的IBD疫苗接种方案对常规应用的针对其他病原体的疫苗的效果,以及针对广泛传播的高毒性IBD病毒(vvIBDV)的可能的保护,是令人感兴趣的。表达IBDV病毒蛋白2的市售火鸡载体疫苗疱疹病毒(vHVT-IBD)和两种IBD活疫苗在商业小鸡中比较了它们对循环B细胞数量的影响,以及接种禽类产生体液免疫应答的能力抵抗不同的抗原,以及诱导针对vvIBDV攻击的保护的能力。这项研究的结果证明了中间体加IBD活疫苗对免疫系统体液分支具有明显的免疫抑制作用。另一方面,未观察到vHVT-IBD疫苗接种对这些参数的可检测的影响。所有测试过的IBD疫苗均能预防临床IBD,尽管没有一种能在商业蛋鸡中诱导无菌免疫。接种vHVT-IBD的禽类在vvIBDV攻击后显示的损伤明显少于IBD活接种或未接种的禽类(P <0.05)。因此,vHVT-IBD可能是常规IBD活疫苗的合适替代品,甚至可以在母源性IBD抗体存在下应用而无需诱导可检测的体液免疫抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号